These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4978602)

  • 21. Studies on heterologous antilymphocyte serum in mice. 8. Effect of immunizing cell type and dose on immunosuppressive potency and content of irrelevant antibody.
    Gozzo JJ; Wood ML; Monaco AP
    Transplantation; 1972 Sep; 14(3):352-7. PubMed ID: 4564931
    [No Abstract]   [Full Text] [Related]  

  • 22. [Toxicity of hyperimune rabbit-mouse thymus antiserum].
    Biege G; von Broen B
    Exp Pathol (Jena); 1970; 4(1):1-5. PubMed ID: 4107737
    [No Abstract]   [Full Text] [Related]  

  • 23. Procarbazine as an immunosuppressant in animals.
    Stewart PB; Bell R
    J Immunol; 1970 Nov; 105(5):1271-7. PubMed ID: 4922984
    [No Abstract]   [Full Text] [Related]  

  • 24. Heterologous antilymphocyte sera and some of their effects.
    Russell PS; Monaco AP
    Transplantation; 1967 Jul; 5(4):Suppl:1086-99. PubMed ID: 4860603
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serologic studies of patients under treatment with xenogenous antilymphocyte globulin].
    Hopf U; Fateh-Moghadam A; Land W; Brendel W
    Klin Wochenschr; 1970 Aug; 48(15):906-13. PubMed ID: 4996980
    [No Abstract]   [Full Text] [Related]  

  • 26. Variations in rabbit antimouse lymphocyte sera caused by lymphocytes of differing origins in the immunizing inocula.
    Miller J; Tanner D; Cohn R
    Transplantation; 1970 Apr; 9(4):352-65. PubMed ID: 4927383
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on the decline in immunosuppressive potency of rabbit anti-mouse thymocyte sera raised by repeated immunization of the same rabbit.
    Ponsford FM; Symes MO
    Folia Biol (Praha); 1971; 17(4):227-35. PubMed ID: 5002373
    [No Abstract]   [Full Text] [Related]  

  • 28. Erasure of immunological memory with anti-lymphocyte serum.
    Lance E
    Nature; 1968 Feb; 217(5128):557-8. PubMed ID: 4867972
    [No Abstract]   [Full Text] [Related]  

  • 29. Improved graft survival after treatment with Bordetella and anti-lymphocyte serum.
    Ptak W; Festenstein H; Asherson GL; Denman AM
    Nature; 1969 Jun; 222(5198):1083-5. PubMed ID: 4306798
    [No Abstract]   [Full Text] [Related]  

  • 30. Tumour nodule formation as an in vivo measure of the suppression of cellular immune response by antilymphocytic serum.
    Stanbridge EJ; Perkins FT
    Nature; 1969 Jan; 221(5175):80-1. PubMed ID: 4882052
    [No Abstract]   [Full Text] [Related]  

  • 31. Mode of recovery from the effects of heterologous anti-lymphocyte serum. I. Recovery of the immune response.
    Jeejeebhoy HF; Singla O
    Immunology; 1972 May; 22(5):789-99. PubMed ID: 4553773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppressive properties of antilymphocyte antibody isolated from a specific immunoadsorbent.
    Wilson BJ; Malley A; Giacometti L; Hill JD
    Transplantation; 1972 Feb; 13(2):189-92. PubMed ID: 4621776
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of antimacrophage, antithymocyte, antilymphocyte and antispleen serum on the immune response in mice.
    Argyris BF; Plotkin DH
    Clin Exp Immunol; 1970 Oct; 7(4):551-64. PubMed ID: 5477268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of hemagglutinin formation in antilymphocyte sera by treatment with homologous antierythrocyte serum.
    Cîrstea M; Boroş I; Suhaciu G
    Rev Roum Physiol; 1972; 9(5):427-32. PubMed ID: 5076054
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies of immunosuppressive potency of rabbit antimouse antisera raised in response to various murine tissues.
    Sutthiwan P; Shorter RG; Hallenbeck GA
    J Surg Res; 1970 Apr; 10(4):151-7. PubMed ID: 4908685
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanism of action of antilymphocyte serum: effect on H-2 antibody formation, induction of allograft immunity, and tolerance to H-2 skin grafts.
    Franco DJ; Monaco AP
    Surg Forum; 1968; 19():175-7. PubMed ID: 4887902
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on heterologous antilymphocyte and antithymocyte sera. IV. Further evidence for a preferential effect on antigen-sensitive cells.
    Barth RF
    J Immunol; 1969 Oct; 103(4):648-54. PubMed ID: 4310736
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparative study on the graft-protective activity of anti-spleen, anti-lymph node and anti-thymus anti-mouse sera.
    Végh P
    Z Immunitatsforsch Exp Klin Immunol; 1971 Nov; 142(4):372-85. PubMed ID: 4257663
    [No Abstract]   [Full Text] [Related]  

  • 39. [The behavior of immunoglobulins and antibody formation during treatment with heterologous antilymphocyte serum].
    Fateh-Moghadam A; Pichlmayr R; Morell C; Knedel M
    Klin Wochenschr; 1967 Jul; 45(13):665-70. PubMed ID: 4172949
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunosuppression of the donor in order to affect chronic secondary disease of the recipient.
    Thierfelder S; Werner J; Götze D
    Blut; 1970; 21(6):384-8. PubMed ID: 4923980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.